Articles Referencing GSK

Elan in Royalty Deal with THRX - Analyst Blog

5/14/2013, 5:06 pm from Zacks.com in Investing, Business, Stocks

Elan Corporation ( ELN ) recently inked a deal with Theravance Inc. ( THRX ) to purchase a participation interest in potential future royalty payments for a one-time cash payment of... Read >>

Wider-than-Expected Loss at ChemoCentryx - Analyst Blog

5/14/2013, 10:55 am from Zacks.com in Investing, Business, Stocks

ChemoCentryx, Inc. ( CCXI ) reported net loss of 28 cents per share in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 27 cents but in line with the year-ago... Read >>

Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog

5/13/2013, 6:06 pm from Zacks.com in Investing, Business, Stocks

GlaxoSmithKline ( GSK ) and partner Theravance, Inc. ( THRX ) recently announced that their chronic obstructive pulmonary disease (COPD) candidate, Breo Ellipta has received US Food and... Read >>

Isis Reports In-Line Loss - Analyst Blog

5/8/2013, 6:25 pm from Zacks.com in Investing, Business, Stocks

Isis Pharmaceuticals Inc. ( ISIS ) reported a net loss of 3 cents per share in the first quarter of 2013, in line with the Zacks Consensus Estimate. The loss was narrower than the year-ago... Read >>

Wider-than-Expected Loss at Dynavax - Analyst Blog

5/7/2013, 11:26 am from Zacks.com in Investing, Business, Stocks

Dynavax Technologies Corporation ( DVAX ) suffered a loss of 11 cents per share in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 10 cents per share but... Read >>

GlaxoSmithKline PLC (GSK) Ex-Dividend Date Scheduled for May 08, 2013

5/7/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks

GlaxoSmithKline PLC ( GSK ) will begin trading ex-dividend on May 08, 2013. A cash dividend payment of $0.5502 per share is scheduled to be paid on July 11, 2013. Shareholders who purchased GSK... Read >>

Netupitant Results Could Roil Tesaro In May

5/6/2013, 9:25 am from SeekingAlpha in Investing, Stocks

By Richard Pearson : Shares of Tesaro Inc. ( TSRO ) have recently traded to new all-time highs and are now sitting at $29.40. The shares have now more than doubled since coming public at... Read >>

This May Be The Best Pharmaceutical Stock for Income Investors

5/3/2013, 9:30 am from StreetAuthority in Investing, Investing Ideas, Stocks

As an income investor, I feel like I've hit the trifecta when I find a low-risk stock that also has consistent dividend growth and a fantastic yield. The high-quality dividend stocks I look... Read >>

Glaxo's Trametinib Delayed - Analyst Blog

5/2/2013, 5:30 pm from Zacks.com in Investing, Business, Stocks

Recently, GlaxoSmithKline ( GSK ) announced that the US Food and Drug Administration (FDA) has extended the review period for Glaxo's oncology candidate, trametinib, by three months. A... Read >>

Glaxo-Impax End Rytary Deal - Analyst Blog

4/30/2013, 4:48 pm from Zacks.com in Investing, Business, Stocks

GlaxoSmithKline ( GSK ) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. ( IPXL ), recently announced the termination of their agreement for Rytary... Read >>

Merck Likely to Beat 1Q Earnings - Analyst Blog

4/29/2013, 4:50 pm from Zacks.com in Investing, Business, Earnings, Stocks

We expect Merck & Co. Inc. ( MRK ) to beat earnings expectations when it reports first-quarter 2013 results before the opening bell on May 1, 2013. Why a Likely Positive Surprise?... Read >>

Amarin's Performance Issues: Here To Stay?

4/29/2013, 1:30 pm from SeekingAlpha in Investing, Stocks

ByDallas Salazar: Amarin Corporation ( AMRN ) is one of the most controversial and debated stocks in recent memory. Plenty of information exists that helps validate both the bull and bear... Read >>

Split News Overshadows Theravance's 1Q Loss - Analyst Blog

4/26/2013, 5:21 pm from Zacks.com in Investing, Business, Stocks

Theravance Inc. 's ( THRX ) first quarter 2013 loss of 39 cents per share was in line with the loss pegged by the Zacks Consensus Estimate. The first quarter 2013 loss compared unfavorably... Read >>

Loss Widens at XenoPort - Analyst Blog

4/25/2013, 1:18 pm from Zacks.com in Investing, Business, Stocks

XenoPort, Inc. ( XNPT ) reported first quarter 2013 loss of 50 cents per share, wider than the Zacks Consensus Estimate of a loss of 42 cents and the year-ago loss of 26 cents per share.... Read >>

Earnings Miss at Glaxo - Analyst Blog

4/25/2013, 12:15 pm from Zacks.com in Investing, Business, Earnings, Stocks

GlaxoSmithKline ( GSK ) reported first quarter earnings of 61 cents per ADS, missing the Zacks Consensus Estimate of 77 cents and the year-ago earnings of 87 cents per ADS. Revenues... Read >>